Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1995 Feb 1;181(2):685–697. doi: 10.1084/jem.181.2.685

Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan

PMCID: PMC2191891  PMID: 7836922

Abstract

The life cycle of Leishmania parasites within the sand fly vector includes the development of extracellular promastigotes from a noninfective, procyclic stage into an infective, metacyclic stage that is uniquely adapted for transmission by the fly and survival in the vertebrate host. These adaptations were explored in the context of the structure and function of the abundant surface lipophosphoglycan (LPG) on Leishmania donovani promastigotes. During metacyclogenesis, the salient structural feature of L. donovani LPG is conserved, involving expression of a phosphoglycan chain made up of unsubstituted disaccharide-phosphate repeats. Two important developmental modifications were also observed. First, the size of the molecule is substantially increased because of a twofold increase in the number of phosphorylated disaccharide repeat units expressed. Second, there is a concomitant decrease in the presentation of terminally exposed sugars. This later property was indicated by the reduced accessibility of terminal galactose residues to galactose oxidase and the loss of binding by the lectins, peanut agglutinin, and concanavalin A, to metacyclic LPG in vivo and in vitro. The loss of lectin binding was not due to downregulation of the capping oligosaccharides as the same beta- linked galactose or alpha-linked mannose-terminating oligosaccharides were present in both procyclic and metacyclic promastigotes. The capping sugars on procyclic LPG were found to mediate procyclic attachment to the sand fly midgut, whereas these same sugars on metacyclic LPG failed to mediate metacyclic binding. And whereas intact metacyclic LPG did not inhibit procyclic attachment, depolymerized LPG inhibited as well as procyclic LPG, demonstrating that the ligands are normally buried. The masking of the terminal sugars is attributed to folding and clustering of the extended phosphoglycan chains, which form densely distributed particulate structures visible on fracture-flip preparations of the metacyclic surface. The exposure and subsequent masking of the terminal capping sugars explains the stage specificity of promastigote attachment to and release from the vector midgut, which are key events in the development of transmissible infections in the fly.

Full Text

The Full Text of this article is available as a PDF (3.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackwell J. M., Ezekowitz R. A., Roberts M. B., Channon J. Y., Sim R. B., Gordon S. Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J Exp Med. 1985 Jul 1;162(1):324–331. doi: 10.1084/jem.162.1.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Da Silva R. P., Hall B. F., Joiner K. A., Sacks D. L. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J Immunol. 1989 Jul 15;143(2):617–622. [PubMed] [Google Scholar]
  3. Franke E. D., McGreevy P. B., Katz S. P., Sacks D. L. Growth cycle-dependent generation of complement-resistant Leishmania promastigotes. J Immunol. 1985 Apr;134(4):2713–2718. [PubMed] [Google Scholar]
  4. Homans S. W., Mehlert A., Turco S. J. Solution structure of the lipophosphoglycan of Leishmania donovani. Biochemistry. 1992 Jan 28;31(3):654–661. doi: 10.1021/bi00118a004. [DOI] [PubMed] [Google Scholar]
  5. Howard M. K., Sayers G., Miles M. A. Leishmania donovani metacyclic promastigotes: transformation in vitro, lectin agglutination, complement resistance, and infectivity. Exp Parasitol. 1987 Oct;64(2):147–156. doi: 10.1016/0014-4894(87)90138-x. [DOI] [PubMed] [Google Scholar]
  6. King D. L., Turco S. J. A ricin agglutinin-resistant clone of Leishmania donovani deficient in lipophosphoglycan. Mol Biochem Parasitol. 1988 Apr;28(3):285–293. doi: 10.1016/0166-6851(88)90013-8. [DOI] [PubMed] [Google Scholar]
  7. Lawyer P. G., Ngumbi P. M., Anjili C. O., Odongo S. O., Mebrahtu Y. B., Githure J. I., Koech D. K., Roberts C. R. Development of Leishmania major in Phlebotomus duboscqi and Sergentomyia schwetzi (Diptera: Psychodidae). Am J Trop Med Hyg. 1990 Jul;43(1):31–43. doi: 10.4269/ajtmh.1990.43.31. [DOI] [PubMed] [Google Scholar]
  8. McConville M. J., Thomas-Oates J. E., Ferguson M. A., Homans S. W. Structure of the lipophosphoglycan from Leishmania major. J Biol Chem. 1990 Nov 15;265(32):19611–19623. [PubMed] [Google Scholar]
  9. McConville M. J., Turco S. J., Ferguson M. A., Sacks D. L. Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage. EMBO J. 1992 Oct;11(10):3593–3600. doi: 10.1002/j.1460-2075.1992.tb05443.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mosser D. M., Edelson P. J. The third component of complement (C3) is responsible for the intracellular survival of Leishmania major. 1987 May 28-Jun 3Nature. 327(6120):329–331. doi: 10.1038/327329b0. [DOI] [PubMed] [Google Scholar]
  11. Pimenta P. F., Saraiva E. M., Rowton E., Modi G. B., Garraway L. A., Beverley S. M., Turco S. J., Sacks D. L. Evidence that the vectorial competence of phlebotomine sand flies for different species of Leishmania is controlled by structural polymorphisms in the surface lipophosphoglycan. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9155–9159. doi: 10.1073/pnas.91.19.9155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pimenta P. F., Turco S. J., McConville M. J., Lawyer P. G., Perkins P. V., Sacks D. L. Stage-specific adhesion of Leishmania promastigotes to the sandfly midgut. Science. 1992 Jun 26;256(5065):1812–1815. doi: 10.1126/science.1615326. [DOI] [PubMed] [Google Scholar]
  13. Pimenta P. F., da Silva R. P., Sacks D. L., da Silva P. P. Cell surface nanoanatomy of Leishmania major as revealed by fracture-flip. A surface meshwork of 44 nm fusiform filaments identifies infective developmental stage promastigotes. Eur J Cell Biol. 1989 Apr;48(2):180–190. [PubMed] [Google Scholar]
  14. Puentes S. M., Da Silva R. P., Sacks D. L., Hammer C. H., Joiner K. A. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. J Immunol. 1990 Dec 15;145(12):4311–4316. [PubMed] [Google Scholar]
  15. Puentes S. M., Sacks D. L., da Silva R. P., Joiner K. A. Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan. J Exp Med. 1988 Mar 1;167(3):887–902. doi: 10.1084/jem.167.3.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sacks D. L., Brodin T. N., Turco S. J. Developmental modification of the lipophosphoglycan from Leishmania major promastigotes during metacyclogenesis. Mol Biochem Parasitol. 1990 Sep-Oct;42(2):225–233. doi: 10.1016/0166-6851(90)90165-i. [DOI] [PubMed] [Google Scholar]
  17. Sacks D. L., Hieny S., Sher A. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. J Immunol. 1985 Jul;135(1):564–569. [PubMed] [Google Scholar]
  18. Sacks D. L., Perkins P. V. Identification of an infective stage of Leishmania promastigotes. Science. 1984 Mar 30;223(4643):1417–1419. doi: 10.1126/science.6701528. [DOI] [PubMed] [Google Scholar]
  19. Sacks D. L. The structure and function of the surface lipophosphoglycan on different developmental stages of Leishmania promastigotes. Infect Agents Dis. 1992 Aug;1(4):200–206. [PubMed] [Google Scholar]
  20. Sacks D. L., da Silva R. P. The generation of infective stage Leishmania major promastigotes is associated with the cell-surface expression and release of a developmentally regulated glycolipid. J Immunol. 1987 Nov 1;139(9):3099–3106. [PubMed] [Google Scholar]
  21. Talamás-Rohana P., Wright S. D., Lennartz M. R., Russell D. G. Lipophosphoglycan from Leishmania mexicana promastigotes binds to members of the CR3, p150,95 and LFA-1 family of leukocyte integrins. J Immunol. 1990 Jun 15;144(12):4817–4824. [PubMed] [Google Scholar]
  22. Thomas J. R., McConville M. J., Thomas-Oates J. E., Homans S. W., Ferguson M. A., Gorin P. A., Greis K. D., Turco S. J. Refined structure of the lipophosphoglycan of Leishmania donovani. J Biol Chem. 1992 Apr 5;267(10):6829–6833. [PubMed] [Google Scholar]
  23. Tolson D. L., Turco S. J., Beecroft R. P., Pearson T. W. The immunochemical structure and surface arrangement of Leishmania donovani lipophosphoglycan determined using monoclonal antibodies. Mol Biochem Parasitol. 1989 Jun 15;35(2):109–118. doi: 10.1016/0166-6851(89)90113-8. [DOI] [PubMed] [Google Scholar]
  24. Turco S. J., Descoteaux A. The lipophosphoglycan of Leishmania parasites. Annu Rev Microbiol. 1992;46:65–94. doi: 10.1146/annurev.mi.46.100192.000433. [DOI] [PubMed] [Google Scholar]
  25. Turco S. J., Wilkerson M. A., Clawson D. R. Expression of an unusual acidic glycoconjugate in Leishmania donovani. J Biol Chem. 1984 Mar 25;259(6):3883–3889. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES